Pharmaceutical compositions comprising human-derived Anti-collapsin response mediator protein 2 (CRMP2) antibodies

TW202637212APending Publication Date: 2026-09-16ONO PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114140720
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-22
Filing Date
2025-10-21
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076342_001
    Figure TWG2TA001076342_001
  • Figure TWG2TA001076342_002
    Figure TWG2TA001076342_002
  • Figure TWG2TA001076342_003
    Figure TWG2TA001076342_003
Patent Text Reader

Abstract

(CRMP2) is established as a therapeutic target in neurodegenerative disorders. Provided are pharmaceutical compositions comprising novel human-derived anti-CRMP2 antibodies as well as fragments, derivatives and variants thereof for CRMP2 targeted therapy.
Need to check novelty before this filing date? Find Prior Art